An Ascending Multiple Dose Study of the Safety, Tolerability and Pharmacokinetics of ERB-041 [prinaberel] Administered Orally to Healthy, Female Japanese Subjects.
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2009
At a glance
- Drugs Prinaberel (Primary)
- Indications Endometriosis
- Focus Adverse reactions; Pharmacokinetics
- 14 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2007 New trial record.